Product Name | MF | CAS | Details |
---|
Acodazole hydrochloride | C20H20ClN5O | 55435-65-9 | Details |
Aceratioside | C17H22O9 | 133084-09-0 | Details |
(R)-OR-S1 | C26H34BrN3O4 | 1809336-19-3 | Details |
A1B11 | C22H25N5O | 1602731-56-5 | Details |
58-G3 | C14H12Cl2N4O5 | 287174-44-1 | Details |
A-933548 | C25H21N5O3 | 1037826-43-9 | Details |
LBW242 | C27H42N4O2 | 867324-12-7 | Details |
Atiratecan | C31H34N6O6 | 867063-97-6 | Details |
BN201 | C25H38FN5O4 | 1361200-34-1 | Details |
Atopaxar hydrochloride | C29H39ClFN3O5 | 474544-83-7 | Details |
NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
MCL-1/BCL-2-IN-4 | C26H23BrN2O5S | 2163793-56-2 | Details |
Pulrodemstat Methylbenzenesulfonate | C31H31F2N5O5S | 2097523-57-2 | Details |
Levomecol | C16H18Cl2N4O7 | 118573-58-3 | Details |
OSMI-2 | C26H25N3O7S2 | 2260542-60-5 | Details |
PKR activator 1 | C16H14N8OS2 | 2283420-62-0 | Details |
PDE1-IN-3 | C18H24N4O | 2370966-46-2 | Details |
PDE9-IN-1 | C17H23FN6O2 | 2305087-92-5 | Details |
PKR activator 2 | C18H16N8OS | 2283422-04-6 | Details |
IDO1-IN-2 | C15H17FN6O4 | 2346614-58-0 | Details |
Flibanserin-d4 | C20H21F3N4O | 2122830-90-2 | Details |
PARP-2-IN-1 | C21H19F4N5O3 | 2115698-83-2 | Details |
OSMI-3 | C32H35N3O9S2 | 2260791-13-5 | Details |
DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
DC4SMe | C35H31ClN5O7PS2 | 615538-47-1 | Details |
Oral antiplatelet agent 1 | C23H24N4O5S | 2299200-91-0 | Details |
OMDM-4 | C29H43NO3 | 616884-65-2 | Details |
Phortress free base | C20H23FN4OS | 741241-36-1 | Details |
HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
OMDM-3 | C29H43NO3 | 616884-64-1 | Details |
JAK-IN-4 | C18H22N4NaO6P | 1400877-37-3 | Details |
JBJ-02-112-05 | C27H20N4O2S | 2748162-29-8 | Details |
Turbinaric acid | C27H44O2 | 56882-00-9 | Details |
(+)-SHIN1 | C24H24N4O2 | 2443966-90-1 | Details |
Syk-IN-3 | C24H28N4O3S | 1312534-69-2 | Details |
RORγt agonist 1 | C24H17F6NO5S | 2377378-89-5 | Details |
Tyk2-IN-9 | C20H17N9 | 2127109-85-5 | Details |
BMS-986163 | C23H28FN2O5P | 1801151-09-6 | Details |
AN11251 | C29H38BFO7 | 2130750-59-1 | Details |
Fobrepodacin disodium | C21H27FN6NaO6P | 1384984-20-6 | Details |
PF-06795071 | C18H17F4N3O3 | 2075629-81-9 | Details |
Alvameline maleate | C13H19N5O4 | 219581-36-9 | Details |
Tecovirimat hydrate | C19H17F3N2O4 | 1162664-19-8 | Details |
AY 9944 dihydrochloride | C22H28Cl2N2 | 1245-84-7 | Details |
Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
Integrin-IN-2 | C27H30N4O3 | 2378617-67-3 | Details |
GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
RIP2 kinase inhibitor 1 | C17H17N5O2S | 2380028-10-2 | Details |
RORγt Inverse agonist 2 | C27H25F8NO5S | 1801197-92-1 | Details |
QPX7728 bis-acetoxy methyl ester | C15H14BFO8 | 2170834-56-5 | Details |
Py-MPB-amino-C3-PBD | C41H44N8O6 | 2412924-07-1 | Details |
(S)-BI 665915 | C24H26N8O2 | 1360550-05-5 | Details |
GLPG-3221 | C30H37F3N2O6 | 2222264-64-2 | Details |
gamma-secretase modulator 1 hydrochloride | C24H25ClN4OS | 2741571-83-3 | Details |
PDE5-IN-2 | C25H21N3O6S | 2244517-61-9 | Details |
TP3011 | C26H26N4O5 | 534605-74-8 | Details |
Isoxsuprine-monoester-1 | C23H31NO4 | 67160-74-1 | Details |
7-Deoxyloganic acid | C16H24O9 | 22487-36-1 | Details |
Mebeverine alcohol D5 | C16H27NO2 | 2070015-15-3 | Details |
Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
SLLN-15 | C19H23N7Se2 | 2403650-93-9 | Details |
Ppc-1 | C21H25NO4 | 1245818-17-0 | Details |
Murizatoclax | C42H57ClN4O5S | 2245848-05-7 | Details |
A457 | C26H33ClN2O3 | 1233923-95-9 | Details |
Ab42-IN-C2 | C15H16Cl2N2O2S2 | 439932-74-8 | Details |
A-424274 | C14H15N3 | 1335145-56-6 | Details |
ACEA1011 | C9H4ClF3N2O2 | 153504-72-4 | Details |
Acetobixan | C16H17NO2S | 380201-24-1 | Details |
Acodazole | 79152-85-5 | Details |
VBIT-3 | C21H19ClF3N3O3 | 2088463-66-3 | Details |
ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
Bocconoline | C22H21NO5 | 1322007-90-8 | Details |
A-953227 | C25H20FN5O3 | 1037826-77-9 | Details |
TP-004 | C17H16F3N5O | 1454299-21-8 | Details |
Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
BIZ 114 | C24H40O3 | 2099120-74-6 | Details |
VDR agonist 1 | C32H51N3O2 | 2269494-43-9 | Details |
(Rac)-PF-06250112 | C22H20F2N6O2 | 1609465-88-4 | Details |
Galidesivir triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
Asteltoxin | C23H30O7 | 79663-49-3 | Details |
A-940894 | C17H21N5 | 1027330-82-0 | Details |
20681-S | C21H29NO5S | 73361-71-4 | Details |
TT-232 TFA(147159-51-1 free base) | C45H58N10O9S2.C2HF3O2 | 2703745-48-4 | Details |
ACJI-99C | C18H19N5O | 1135195-64-0 | Details |
(+/-)-Terreic acid | C7H6O4 | 15255-24-0 | Details |
UB 165 fumarate | C13H15ClN2.C4H4O4 | 2454492-43-2 | Details |
TLC3407-3786 | C19H19N3O4 | 896356-25-5 | Details |
Oxaquin | C31H33F2N4O11P | 790704-50-6 | Details |
13-Hydroxystevane | C20H34O | 5749-44-0 | Details |
A2B57 | C22H19N5O | 1602733-73-2 | Details |
Isoproterenol bitartrate | C11H17NO3.C4H6O6 | 59-60-9 | Details |
PPTN | C29H24F3NO2 | 1160271-30-6 | Details |
Lesopitron HCl | C15H21ClN6.ClH | 132449-88-8 | Details |
5-Hydroxylansoprazole sulfone | C16H14F3N3O4S | 131927-00-9 | Details |
JMV 2959 hydrochloride (925238-89-7 free base) | C30H32N6O2.ClH | 2448414-54-6 | Details |
(S)-Gyramide A | C21H27FN2O3S | 1000592-48-2 | Details |
Product Total: Product Page: | ||||
138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 |